Connect. Partner. Innovate.
The BIO International Convention is the largest global event for the biotechnology industry and attracts the biggest names in biotech, offers key networking and partnering opportunities, and provides insights and inspiration on the major trends affecting the industry. The event features keynotes and sessions from key policymakers, scientists, CEOs, and celebrities. Past speakers include President George W. Bush, President Bill Clinton, Former Prime Minister of Great Britain and Northern Ireland Tony Blair, Michael J. Fox, Sir Elton John, Her Majesty Queen Noor of Jordan, and General Colin Powell, among many others. The Convention also features the BIO Business Forum (One-on-One Partnering), hundreds of sessions covering biotech trends, policy issues and technological innovations, and the world's largest biotechnology exhibition - the BIO Exhibition.
BIO performs many services for members, but none of them are more visible than the BIO International Convention, the largest biotechnology event in the world. The BIO International Convention helps BIO fulfill its mission to help grow the global biotech industry. Profits from the BIO International Convention are returned to the biotechnology industry by supporting BIO programs and initiatives. BIO works throughout the year to create a policy environment that enables the industry to continue to fulfill its vision of bettering the world through biotechnology innovation.
History and Background
The first BIO International Convention was held in 1993 and attracted approximately 1,400 attendees. The largest event to date was in Boston, Mass. in 2007, with more than 22,000 attendees. Media coverage has increased as well, from a smattering of trade-press reporters in the early years to more than 400 reporters in recent years. Many of the session topics are focused on perennial themes: raising capital in the venture and public markets; FDA, USDA, and EPA regulation; and patenting trends. Growth of the meeting, and BIO overall, has paralleled that of the young, dynamic industry BIO represents.
2012 Event Recap
The 2012 BIO International Convention wrapped up at the Boston Convention & Exhibition Center in Boston, MA with a record number of partnering meetings, increased international attendance and participation, and panel sessions on the latest scientific, policy and business opportunities and challenges facing the biotechnology industry. The event drew 16,505 industry leaders from 49 states and 65 countries.
BIO President & CEO, Jim Greenwood, moderated a conversation between Former Secretaries of the Treasury Robert E. Rubin and Henry M. Paulson, Jr. at Tuesday's keynote. Wednesday's keynote featured a discussion among: Joshua Boger, PhD, Founder and CEO (Ret.), Vertex Pharmaceuticals Incorporated; Brian Atwood, Managing Director, Versant Ventures; Rachel K. King, CEO, GlycoMimetics, Inc; Christopher A. Viehbacher, CEO, Sanofi, Chairman, Enzyme; and H. Thomas Watkins, President & CEO, Human Genome Sciences. The Convention program featured more than 125 breakout sessions across 14 tracks, which included Innovations in Vaccines, Health Policy and Reimbursement, Biosecurity, Achieving Regulatory Approval and Complaince, Food and Agriculture, Career Development, and Biofuels and Biobased Chemicals.
The top 10 largest international delegations included (in order): Canada, UK, Germany, France, Japan, South Korea, Spain, Australia, China, and Brazil.
The event attracted 6 U.S. Governors and more than 100 international public officials.
The BIO Business Forum hosted a record breaking 25,291 partnering meetings (up from 21,183 in 2011) between 2,900 companies and featured 190 company presentations. The BIO Business Forum Partnering Report indicated that there is high demand for Phase III assets as well as immunology and respiratory therapeutic areas compared to 2011. In addition, CNS, the therapeutic area with highest interest in 2011, only drew an average level of interest in 2012.
The BIO Exhibition featured more than 2,000 exhibitors and covered 180,550 square feet with 60 state and international pavilions. 2012 also brought the extension of partnering to exhibitors in their booths; Exhibitor Partnering hosted 4,300 partnering meetings within the BIO Exhibition.